149 related articles for article (PubMed ID: 23201725)
1. Lyophilized wafers comprising carrageenan and pluronic acid for buccal drug delivery using model soluble and insoluble drugs.
Kianfar F; Antonijevic M; Chowdhry B; Boateng JS
Colloids Surf B Biointerfaces; 2013 Mar; 103():99-106. PubMed ID: 23201725
[TBL] [Abstract][Full Text] [Related]
2. Development and physico-mechanical characterization of carrageenan and poloxamer-based lyophilized matrix as a potential buccal drug delivery system.
Kianfar F; Ayensu I; Boateng JS
Drug Dev Ind Pharm; 2014 Mar; 40(3):361-9. PubMed ID: 23600651
[TBL] [Abstract][Full Text] [Related]
3. Novel films for drug delivery via the buccal mucosa using model soluble and insoluble drugs.
Kianfar F; Chowdhry BZ; Antonijevic MD; Boateng JS
Drug Dev Ind Pharm; 2012 Oct; 38(10):1207-20. PubMed ID: 22204701
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of freeze-dried wafers and solvent evaporated films as potential drug delivery systems to mucosal surfaces.
Boateng JS; Auffret AD; Matthews KH; Humphrey MJ; Stevens HN; Eccleston GM
Int J Pharm; 2010 Apr; 389(1-2):24-31. PubMed ID: 20083177
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of laminated thiolated chitosan-based freeze-dried wafers for potential buccal delivery of macromolecules.
Boateng JS; Ayensu I
Drug Dev Ind Pharm; 2014 May; 40(5):611-8. PubMed ID: 24506457
[TBL] [Abstract][Full Text] [Related]
6. Development and functional characterization of composite freeze dried wafers for potential delivery of low dose aspirin for elderly people with dysphagia.
Farias S; Boateng JS
Int J Pharm; 2018 Dec; 553(1-2):65-83. PubMed ID: 30312748
[TBL] [Abstract][Full Text] [Related]
7. Poloxamer 407 microspheres for orotransmucosal drug delivery. Part I: formulation, manufacturing and characterization.
Albertini B; Passerini N; Di Sabatino M; Monti D; Burgalassi S; Chetoni P; Rodriguez L
Int J Pharm; 2010 Oct; 399(1-2):71-9. PubMed ID: 20696227
[TBL] [Abstract][Full Text] [Related]
8. Development and physico-mechanical characterisation of lyophilised chitosan wafers as potential protein drug delivery systems via the buccal mucosa.
Ayensu I; Mitchell JC; Boateng JS
Colloids Surf B Biointerfaces; 2012 Mar; 91():258-65. PubMed ID: 22130527
[TBL] [Abstract][Full Text] [Related]
9. Characterization of gelation process and drug release profile of thermosensitive liquid lecithin/poloxamer 407 based gels as carriers for percutaneous delivery of ibuprofen.
Djekic L; Krajisnik D; Martinovic M; Djordjevic D; Primorac M
Int J Pharm; 2015 Jul; 490(1-2):180-9. PubMed ID: 26002567
[TBL] [Abstract][Full Text] [Related]
10. In vitro drug release studies of polymeric freeze-dried wafers and solvent-cast films using paracetamol as a model soluble drug.
Boateng JS; Matthews KH; Auffret AD; Humphrey MJ; Stevens HN; Eccleston GM
Int J Pharm; 2009 Aug; 378(1-2):66-72. PubMed ID: 19477255
[TBL] [Abstract][Full Text] [Related]
11. Pluronic lecithin organogel as a topical drug delivery system.
Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A
Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074
[TBL] [Abstract][Full Text] [Related]
12. Nanosizing of a drug/carrageenan complex to increase solubility and dissolution rate.
Dai WG; Dong LC; Song YQ
Int J Pharm; 2007 Sep; 342(1-2):201-7. PubMed ID: 17560055
[TBL] [Abstract][Full Text] [Related]
13. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
[TBL] [Abstract][Full Text] [Related]
14. Coprocessing via spray drying as a formulation platform to improve the compactability of various drugs.
Gonnissen Y; Verhoeven E; Peeters E; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2008 May; 69(1):320-34. PubMed ID: 18248803
[TBL] [Abstract][Full Text] [Related]
15. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
16. Development of fully amorphous dispersions of a low T(g) drug via co-spray drying with hydrophilic polymers.
Zhao M; Barker SA; Belton PS; McGregor C; Craig DQ
Eur J Pharm Biopharm; 2012 Nov; 82(3):572-9. PubMed ID: 22922419
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Carrageenan Aerogel Microparticles as a Potential Drug Carrier.
Obaidat RM; Alnaief M; Mashaqbeh H
AAPS PharmSciTech; 2018 Jul; 19(5):2226-2236. PubMed ID: 29736886
[TBL] [Abstract][Full Text] [Related]
18. Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettability.
Miriyala N; Ouyang D; Perrie Y; Lowry D; Kirby DJ
Eur J Pharm Biopharm; 2017 Jun; 115():197-205. PubMed ID: 28284728
[TBL] [Abstract][Full Text] [Related]
19. Formulation, characterisation and stabilisation of buccal films for paediatric drug delivery of omeprazole.
Khan S; Boateng JS; Mitchell J; Trivedi V
AAPS PharmSciTech; 2015 Aug; 16(4):800-10. PubMed ID: 25559373
[TBL] [Abstract][Full Text] [Related]
20. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.
Newa M; Bhandari KH; Oh DH; Kim YR; Sung JH; Kim JO; Woo JS; Choi HG; Yong CS
Arch Pharm Res; 2008 Nov; 31(11):1497-507. PubMed ID: 19023548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
